Shuye Lin

642 total citations
18 papers, 270 citations indexed

About

Shuye Lin is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Shuye Lin has authored 18 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Surgery. Recurrent topics in Shuye Lin's work include Epigenetics and DNA Methylation (6 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cancer-related gene regulation (3 papers). Shuye Lin is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cancer-related gene regulation (3 papers). Shuye Lin collaborates with scholars based in China, United States and Ethiopia. Shuye Lin's co-authors include Rui Xing, Youyong Lu, Jiaqiang Huang, Ji Ming Wang, Jing Yan, Yuanming Pan, Bing Yang, Jiantao Cui, Yuqi He and Haichao Wang and has published in prestigious journals such as Life Sciences, Antioxidants and Redox Signaling and Phytotherapy Research.

In The Last Decade

Shuye Lin

18 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuye Lin China 11 162 71 51 47 46 18 270
Yingxin Sun China 10 191 1.2× 86 1.2× 46 0.9× 33 0.7× 44 1.0× 33 324
Xiaoqing Su China 11 135 0.8× 78 1.1× 66 1.3× 44 0.9× 21 0.5× 20 287
Ok‐Seon Kwon South Korea 11 219 1.4× 78 1.1× 64 1.3× 26 0.6× 41 0.9× 21 320
Yannasittha Jiramongkol United Kingdom 8 261 1.6× 99 1.4× 59 1.2× 26 0.6× 29 0.6× 12 373
Cong Huang China 13 154 1.0× 74 1.0× 50 1.0× 24 0.5× 97 2.1× 31 312
Lakshmipathi Vadlakonda India 5 219 1.4× 64 0.9× 43 0.8× 32 0.7× 24 0.5× 7 299
Yarui Ma China 6 177 1.1× 96 1.4× 49 1.0× 30 0.6× 104 2.3× 10 278
Shidong Lv China 10 252 1.6× 97 1.4× 74 1.5× 28 0.6× 111 2.4× 25 386
Qiong Xiao China 12 171 1.1× 89 1.3× 89 1.7× 38 0.8× 76 1.7× 28 336
Chaobo Hu China 5 203 1.3× 98 1.4× 48 0.9× 65 1.4× 30 0.7× 6 342

Countries citing papers authored by Shuye Lin

Since Specialization
Citations

This map shows the geographic impact of Shuye Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuye Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuye Lin more than expected).

Fields of papers citing papers by Shuye Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuye Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuye Lin. The network helps show where Shuye Lin may publish in the future.

Co-authorship network of co-authors of Shuye Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shuye Lin. A scholar is included among the top collaborators of Shuye Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuye Lin. Shuye Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pang, Yuepeng, et al.. (2025). Epigenetic Insights Into Aging: Emerging Roles of Natural Products in Therapeutic Interventions. Phytotherapy Research. 39(7). 3300–3322. 1 indexed citations
2.
Zhang, Huan, et al.. (2025). Epigenetic regulators combined with tumour immunotherapy: current status and perspectives. Clinical Epigenetics. 17(1). 51–51. 7 indexed citations
3.
Ren, Lehao, et al.. (2024). Ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in Breast Cancer. Current Medical Science. 44(1). 156–167. 3 indexed citations
4.
Zhang, Huan, et al.. (2024). Garlic‐derived compounds: Epigenetic modulators and their antitumor effects. Phytotherapy Research. 38(3). 1329–1344. 8 indexed citations
5.
Lin, Shuye, Hanli Xu, Ziyu Wang, et al.. (2023). UHRF1/DNMT1–MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer. Acta Pharmaceutica Sinica B. 13(5). 2086–2106. 10 indexed citations
6.
Wang, Feng, et al.. (2023). Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods. Translational Cancer Research. 12(5). 1112–1127. 3 indexed citations
7.
Xu, Hanli, Shuye Lin, Ziyun Zhou, et al.. (2023). New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine. Cellular and Molecular Immunology. 20(7). 739–776. 30 indexed citations
8.
Lin, Shuye, Hongyun Ruan, Cong Zhao, et al.. (2023). Acquired resistance to EGFR-TKIs in NSCLC mediates epigenetic downregulation of MUC17 by facilitating NF-κB activity via UHRF1/DNMT1 complex. International Journal of Biological Sciences. 19(3). 832–851. 14 indexed citations
9.
Li, Wěi, Shuye Lin, Yuqi He, Jinghui Wang, & Yuanming Pan. (2023). Deep learning survival model for colorectal cancer patients (DeepCRC) with Asian clinical data compared with different theories. Archives of Medical Science. 19(1). 264–269. 11 indexed citations
10.
Fu, Yanxia, Chen Zhang, Ziyu Wang, et al.. (2023). Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation. Life Sciences. 334. 122189–122189. 10 indexed citations
11.
Lin, Shuye, Fangchao Liu, Cong Zhao, et al.. (2022). Key Factors Associated With Administration of Ventilator Support After Thymoma Resection. Journal of Surgical Research. 277(2). 67–75. 1 indexed citations
12.
Lin, Shuye, Jianhui Li, Bin Liu, et al.. (2021). Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma. Oncology Reports. 45(5). 11 indexed citations
13.
Pan, Yuanming, Xin Wang, Yuqi He, et al.. (2020). Tumor suppressor ATP4B serve as a promising biomarker for worsening of gastric atrophy and poor differentiation. Gastric Cancer. 24(2). 314–326. 10 indexed citations
14.
Lin, Shuye, Yaping Zhang, Yingqi Hu, et al.. (2019). Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-κB-mediated expression of CEACAM1-3S in human gastric cancer. Gastric Cancer. 22(5). 941–954. 18 indexed citations
15.
Yan, Jing, Bing Yang, Shuye Lin, Rui Xing, & Youyong Lu. (2018). Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer. Gastric Cancer. 22(2). 302–313. 44 indexed citations
16.
Lin, Shuye, Xiaoyue Wang, Meiying Zhang, et al.. (2017). Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma. Journal of Molecular Medicine. 95(11). 1237–1249. 14 indexed citations
17.
Lin, Shuye, Xiaoyue Wang, Yuanming Pan, et al.. (2017). Silencing of ATP4B of ATPase H+/K+ Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 25(3). 317–329. 19 indexed citations
18.
Pan, Yuanming, Shuye Lin, Rui Xing, et al.. (2016). Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation. Antioxidants and Redox Signaling. 24(15). 839–854. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingxin Sun Breakdown of academic impact, for papers by Xiaoqing Su Breakdown of academic impact, for papers by Ok‐Seon Kwon Breakdown of academic impact, for papers by Yannasittha Jiramongkol Breakdown of academic impact, for papers by Cong Huang Breakdown of academic impact, for papers by Lakshmipathi Vadlakonda Breakdown of academic impact, for papers by Yarui Ma Breakdown of academic impact, for papers by Shidong Lv Breakdown of academic impact, for papers by Qiong Xiao Breakdown of academic impact, for papers by Chaobo Hu
Rankless by CCL
2026